450 related articles for article (PubMed ID: 28964949)
21. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
22. New supersaturating drug delivery system as strategy to improve apparent solubility of candesartan cilexetil in biorelevant medium.
Pinto JMO; Leão AF; Alves GF; Mendes C; França MT; Fernandes D; Stulzer HK
Pharm Dev Technol; 2020 Jan; 25(1):89-99. PubMed ID: 31583925
[TBL] [Abstract][Full Text] [Related]
23. Enhanced dissolution and oral absorption of tacrolimus by supersaturable self-emulsifying drug delivery system.
Lee DR; Ho MJ; Jung HJ; Cho HR; Park JS; Yoon SH; Choi YS; Choi YW; Oh CH; Kang MJ
Int J Nanomedicine; 2016; 11():1109-17. PubMed ID: 27051286
[TBL] [Abstract][Full Text] [Related]
24. Understanding the interaction between Soluplus® and biorelevant media components.
Pinto JMO; Rengifo AFC; Mendes C; Leão AF; Parize AL; Stulzer HK
Colloids Surf B Biointerfaces; 2020 Mar; 187():110673. PubMed ID: 31812452
[TBL] [Abstract][Full Text] [Related]
25. Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers.
Ng CL; Lee SE; Lee JK; Kim TH; Jang WS; Choi JS; Kim YH; Kim JK; Park JS
Int J Pharm; 2016 Oct; 512(1):314-321. PubMed ID: 27593897
[TBL] [Abstract][Full Text] [Related]
26. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
[TBL] [Abstract][Full Text] [Related]
27. Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.
Al-Obaidi H; Lawrence MJ; Buckton G
J Pharm Pharmacol; 2016 Nov; 68(11):1373-1383. PubMed ID: 27696396
[TBL] [Abstract][Full Text] [Related]
28. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
[TBL] [Abstract][Full Text] [Related]
29. Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug-polymer interactions on drug dissolution.
Pandey MM; Jaipal A; Charde SY; Goel P; Kumar L
Pharm Dev Technol; 2016; 21(4):463-74. PubMed ID: 25777532
[TBL] [Abstract][Full Text] [Related]
30. Impact of surfactants on the crystal growth of amorphous celecoxib.
Mosquera-Giraldo LI; Trasi NS; Taylor LS
Int J Pharm; 2014 Jan; 461(1-2):251-7. PubMed ID: 24333451
[TBL] [Abstract][Full Text] [Related]
31. Electrospun fibers as potential carrier systems for enhanced drug release of perphenazine.
Bruni G; Maggi L; Tammaro L; Lorenzo RD; Friuli V; D Aniello S; Maietta M; Berbenni V; Milanese C; Girella A; Marini A
Int J Pharm; 2016 Sep; 511(1):190-197. PubMed ID: 27418562
[TBL] [Abstract][Full Text] [Related]
32. A comparative study between hot-melt extrusion and spray-drying for the manufacture of anti-hypertension compatible monolithic fixed-dose combination products.
Kelleher JF; Gilvary GC; Madi AM; Jones DS; Li S; Tian Y; Almajaan A; Senta-Loys Z; Andrews GP; Healy AM
Int J Pharm; 2018 Jul; 545(1-2):183-196. PubMed ID: 29730176
[TBL] [Abstract][Full Text] [Related]
33. Effects of Polymer/Surfactant as Carriers on the Solubility and Dissolution of Fenofibrate Solid Dispersion.
Yang B; Wu L; Ke J; Zhou L; Chen M; Li S; Feng X
AAPS PharmSciTech; 2019 Feb; 20(3):102. PubMed ID: 30723877
[TBL] [Abstract][Full Text] [Related]
34. Synergetic effect of nucleation and crystal growth inhibitor on in vitro-in vivo performance of supersaturable lacidipine solid dispersion.
Guan J; Huan X; Liu Q; Jin L; Wu H; Zhang X; Mao S
Int J Pharm; 2019 Jul; 566():594-603. PubMed ID: 31175988
[TBL] [Abstract][Full Text] [Related]
35. Investigation of Polymer/Surfactant Interactions and Their Impact on Itraconazole Solubility and Precipitation Kinetics for Developing Spray-Dried Amorphous Solid Dispersions.
Deshpande TM; Shi H; Pietryka J; Hoag SW; Medek A
Mol Pharm; 2018 Mar; 15(3):962-974. PubMed ID: 29345955
[TBL] [Abstract][Full Text] [Related]
36. Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions.
Thiry J; Broze G; Pestieau A; Tatton AS; Baumans F; Damblon C; Krier F; Evrard B
Eur J Pharm Sci; 2016 Mar; 85():94-105. PubMed ID: 26850682
[TBL] [Abstract][Full Text] [Related]
37. Non-invasive insight into the release mechanisms of a poorly soluble drug from amorphous solid dispersions by confocal Raman microscopy.
Punčochová K; Vukosavljevic B; Hanuš J; Beránek J; Windbergs M; Štěpánek F
Eur J Pharm Biopharm; 2016 Apr; 101():119-25. PubMed ID: 26861928
[TBL] [Abstract][Full Text] [Related]
38. Solubility and dissolution performances of spray-dried solid dispersion of Efavirenz in Soluplus.
Lavra ZM; Pereira de Santana D; Ré MI
Drug Dev Ind Pharm; 2017 Jan; 43(1):42-54. PubMed ID: 27349377
[TBL] [Abstract][Full Text] [Related]
39. Bottom-Up and Top-Down Approaches to Explore Sodium Dodecyl Sulfate and Soluplus on the Crystallization Inhibition and Dissolution of Felodipine Extrudates.
Chen J; Chen Y; Huang W; Wang H; Du Y; Xiong S
J Pharm Sci; 2018 Sep; 107(9):2366-2376. PubMed ID: 29738699
[TBL] [Abstract][Full Text] [Related]
40. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
